Abstract
Joanna Drabinska, Lucia O'Connor, Caoilin McClean, Siobhán McClean
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Future Therapies for Cystic Fibrosis
10.1038/s41467-023-36244-2 · 2023
Pseudomonas aeruginosa Evasion of Phagocytosis Is Mediated by Loss of Swimming Motility and Is Independent of Flagellum Expression
10.1128/iai.00144-10 · 2010
Persistence and Evolution of Pseudomonas aeruginosa Following Initiation of Highly Effective Modulator Therapy in Cystic Fibrosis
10.1128/mbio.00519-24 · 2024
Tyrosine‐Phosphorylated Bacterial Effector Proteins: The Enemies Within
10.1016/j.tim.2005.08.002 · 2005
Epoxide‐Mediated CifR Repression of cif Gene Expression Utilizes Two Binding Sites in Pseudomonas aeruginosa
10.1128/jb.00984-12 · 2012
The Bacterial ParA‐ParB Partitioning Proteins
10.1016/s0168-1656(01)00293-0 · 2001
Modelling Co‐Infection of the Cystic Fibrosis Lung by Pseudomonas aeruginosa and Burkholderia cenocepacia Reveals Influences on Biofilm Formation and Host Response
10.1371/journal.pone.0052330 · 2012
Pseudomonas aeruginosa Microevolution During Cystic Fibrosis Lung Infection Establishes Clones With Adapted Virulence
10.1164/rccm.200812-1943oc · 2009
Sequence Diversity of the mucABD Locus in Pseudomonas aeruginosa Isolates From Patients With Cystic Fibrosis
10.1099/mic.0.29175-0 · 2006
Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance During Long‐Term Infections in the Airways of Cystic Fibrosis Patients
10.1128/aac.02142-19 · 2020
Role of Protein Phosphorylation on Serine/Threonine and Tyrosine in the Virulence of Bacterial Pathogens
10.1159/000089648 · 2005
Bacterial Adaptation During Chronic Respiratory Infections
10.3390/pathogens4010066 · 2015
Phenotypic Characterization of an International Pseudomonas aeruginosa Reference Panel: Strains of Cystic Fibrosis (CF) Origin Show Less In Vivo Virulence Than Non‐CF Strains
10.1099/mic.0.000155 · 2015
Recombination Is a Key Driver of Genomic and Phenotypic Diversity in a Pseudomonas aeruginosa Population During Cystic Fibrosis Infection
10.1038/srep07649 · 2015
ScanProsite: Detection of PROSITE Signature Matches and ProRule‐Associated Functional and Structural Residues in Proteins
10.1093/nar/gkl124 · 2006
Developing an International Pseudomonas aeruginosa Reference Panel
10.1002/mbo3.141 · 2013
Coexistence and Within‐Host Evolution of Diversified Lineages of Hypermutable Pseudomonas aeruginosa in Long‐Term Cystic Fibrosis Infections
10.1371/journal.pgen.1004651 · 2014
Microarray Analysis Reveals Induction of Lipoprotein Genes in Mucoid Pseudomonas aeruginosa: Implications for Inflammation in Cystic Fibrosis
10.1128/iai.72.9.5012-5018.2004 · 2004
Genomic Characterisation of an International Pseudomonas aeruginosa Reference Panel Indicates That the Two Major Groups Draw Upon Distinct Mobile Gene Pools
10.1093/femsle/fny120 · 2018
Integrated Analysis of Transcriptomic and Proteomic Data
10.2174/1389202911314020003 · 2013
Sequence‐Verified Two‐Allele Transposon Mutant Library for Pseudomonas aeruginosa PAO1
10.1128/jb.01479-12 · 2012
Dynamics of Adaptive Microevolution of Hypermutable Pseudomonas aeruginosa During Chronic Pulmonary Infection in Patients With Cystic Fibrosis
10.1086/599360 · 2009
Adaptation of Pseudomonas aeruginosa During Persistence in the Cystic Fibrosis Lung
10.1016/j.ijmm.2010.08.008 · 2010
Comprehensive Transposon Mutant Library of Pseudomonas aeruginosa
10.1073/pnas.2036282100 · 2003
Regional Isolation Drives Bacterial Diversification Within Cystic Fibrosis Lungs
10.1016/j.chom.2015.07.006 · 2015
Pseudomonas aeruginosa: An Audacious Pathogen With an Adaptable Arsenal of Virulence Factors
10.3390/ijms22063128 · 2021
Diverse Partners of the Partitioning ParB Protein in Pseudomonas aeruginosa
10.1128/spectrum.04289-22 · 2023
General and Condition‐Specific Essential Functions of Pseudomonas aeruginosa
10.1073/pnas.1422186112 · 2015
Cystic Fibrosis‐Niche Adaptation of Pseudomonas aeruginosa Reduces Virulence in Multiple Infection Hosts
10.1371/journal.pone.0035648 · 2012
Protein Post‐Translational Modifications in Bacteria
10.1038/s41579-019-0243-0 · 2019
NetPhosBac – A Predictor for Ser/Thr Phosphorylation Sites in Bacterial Proteins
10.1002/pmic.200800285 · 2009
Catching a Walker in the Act‐DNA Partitioning by ParA Family of Proteins
10.3389/fmicb.2022.856547 · 2022
High Peripheral Blood th17 Percent Associated With Poor Lung Function in Cystic Fibrosis
10.1371/journal.pone.0120912 · 2015
Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients With Cystic Fibrosis
10.1128/jb.01651-09 · 2010
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People With Cystic Fibrosis: A Clinical Trial
10.1164/rccm.202108-1986oc · 2022
The Wsp System of Pseudomonas aeruginosa Links Surface Sensing and Cell Envelope Stress
10.1073/pnas.2117633119 · 2022
The PRIDE Database and Related Tools and Resources in 2019: Improving Support for Quantification Data
10.1093/nar/gky1106 · 2019
A New Mathematical Model for Relative Quantification in Real‐Time RT‐PCR
10.1093/nar/29.9.e45 · 2001
Genome‐Wide Identification of Genetic Requirements of Pseudomonas aeruginosa PAO1 for Rat Cardiomyocyte (H9C2) Infection by Insertion Sequencing
10.1016/j.meegid.2022.105231 · 2022
Investigating the Correspondence Between Transcriptomic and Proteomic Expression Profiles Using Coupled Cluster Models
10.1093/bioinformatics/btn553 · 2008
An Orphan Sensor Kinase Controls Quinolone Signal Production via MexT in Pseudomonas aeruginosa
10.1111/j.1365-2958.2011.07947.x · doi-reference
Use of Cell Wall Stress to Characterize σ22(AlgT/U) Activation by Regulated Proteolysis and Its Regulon in Pseudomonas aeruginosa
10.1111/j.1365-2958.2009.06635.x · doi-reference
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
10.1016/j.tim.2016.01.008 · doi-reference
Pseudomonas aeruginosa Genome Database and PseudoCAP: Facilitating Community‐Based, Continually Updated, Genome Annotation
10.1093/nar/gki047 · doi-reference
Enhanced Annotations and Features for Comparing Thousands of Pseudomonas Genomes in the Pseudomonas Genome Database
10.1093/nar/gkv1227 · doi-reference
Divergent, Coexisting Pseudomonas aeruginosa Lineages in Chronic Cystic Fibrosis Lung Infections
10.1164/rccm.201409-1646oc · doi-reference
Tyrosine Phosphorylation and Bacterial Virulence
10.1038/ijos.2012.6 · doi-reference
Emerging Therapies Against Infections With Pseudomonas aeruginosa
10.12688/f1000research.19509.1 · doi-reference
The STRING Database in 2023: Protein‐Protein Association Networks and Functional Enrichment Analyses for Any Sequenced Genome of Interest
10.1093/nar/gkac1000 · doi-reference
Roles of Two‐Component Systems in Pseudomonas aeruginosa Virulence
10.3390/ijms222212152 · doi-reference
Complete Genome Sequence of Pseudomonas aeruginosa PAO1, an Opportunistic Pathogen
10.1038/35023079 · doi-reference
CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
10.3390/cells11071243 · doi-reference
Environmental Reservoirs for exoS+ and exoU+ Strains of Pseudomonas aeruginosa
10.1111/1758-2229.12653 · doi-reference
Pseudomonas aeruginosa Adaptation and Evolution in Patients With Cystic Fibrosis
10.1038/s41579-020-00477-5 · doi-reference
Cyclic di‐GMP: The First 25 Years of a Universal Bacterial Second Messenger
10.1128/mmbr.00043-12 · doi-reference